These investments, sponsored by the Department of Health, are providing funding, which is applied for by the NHS hospitals and released in so-called ‘waves’. Recently, the awarded tenders in the 9th wave were announced.
Among these, the Swedish firm Elekta, which specialises in advanced radiation therapy, comprehensive cancer management and non-invasive treatment of brain disorders, has been appointed to deliver six advanced digital linear accelerators for radiation therapy to five UK hospitals: Guy’s Hospital in London, New Cross Hospital in Wolverhampton, Queen Elizabeth Hospital in Birmingham, Poole General Hospital and Southampton General.
In total, the orders are valued at over £6 million.
The hospitals will install Elekta Synergy, fully equipped with precision IMRT, real-time portal imaging and the most clinically advanced 3D X-ray volume imaging for Image Guided Radiation Therapy (IGRT).
In addition to choosing Elekta’s clinical solutions, three of the hospitals will install image-guided treatment management systems from IMPAC Medical Systems, an Elekta company. These will connect treatment planning systems, imaging systems and the radiation therapy delivery equipment - regardless of manufacturer.